Article Top Ad
Reading Time: 2 minutes

TORONTO–(BUSINESS WIRE)–Synaptive Medical Inc., a leader in surgical planning and navigation
technology, announced today that the Company will receive a grant under
the Industry Consortium for Image Guided Therapy (ICIGT) network from
the Government of Canada’s Innovation, Science and Economic Development
sector. Through an innovation competition sponsored by the Government of
Canada, Sunnybrook Research Institute submitted a winning proposal, in
which Synaptive is a named partner. The proposal is a targeted
commercialization initiative that leverages progress in artificial
intelligence (AI) facilitated data processing and outstanding research
and business expertise in Image-Guided Therapy (IGT).

In a ceremony last week, at the Sunnybrook Health Sciences Centre,
Minister of Innovation, Science and Economic Development, The Honorable
Navdeep Bains, announced an investment of up to $49 million that will
support the ICIGT network of more than 78 partners. The investment will
support ICIGT’s estimated $126 million project to quicken the
application of AI and machine learning technologies for more accurate
image-guided therapies such as MRIs, CT scans and ultrasounds.
Synaptive’s integrated suite of medical technology products are tailored
to this area of innovation, and this partnership, along with the
additional funding, will revolutionize the healthcare landscape with
respect to AI- and machine learning-supported diagnostics and treatment.

The Strategic Innovation Fund made the above investment through a
program designed to attract and support high-quality business
investments in Canada’s most dynamic and innovative sectors. Through
this grant, Canadians will benefit from better health outcomes, faster
diagnoses and safer treatments. The collaborative ICIGT public-private
network will shorten the pathway to market for promising high-impact new
technologies that help to address gaps in Canadian health care
structures.

About Synaptive Medical
Synaptive Medical Inc., a
Toronto-based medical device and technology company, designs hardware
and software that cross traditional barriers in hospitals and improve
patient care in and beyond the operating room. Synaptive’s Modus V™ and
integrated BrightMatter™ solutions—including surgical planning,
navigation and visualization, and an informatics platform—give leading
clinicians and healthcare systems the information they need to ensure
the best possible outcomes for patients.

Contacts

Andrew Mielach
Associate Director
LifeSci Public Relations
(646)
876-5868
[email protected]